WAKEFIELD, Mass. – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced that it has received preliminary approval for a processing license by the Utah Department of Agriculture and Food (“UDAF”).
The notice grants Curaleaf permission to begin the build out of its processing facility immediately, with final approval of Curaleaf’s Tier 1 medical cannabis processing license imminent. This follows the UDAF’s recently announced Notice of Intent to Award a medical pharmacy license to Curaleaf.
“We are pleased with the progress we are making in the state of Utah. Aligned with our strategy, this processing license puts us closer to achieving vertical integration in the state, which gives us greater control of production while lowering costs for patients,” said Joseph Lusardi, Chief Executive Officer of Curaleaf. “We look forward to providing the people of Utah with increased access to high quality and reliable cannabis products.”
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading vertically integrated multi-state cannabis operator in the United States. It is a high-growth cannabis company with a national brand known for quality, trust and reliability. The company is positioned in highly populated, limited license states, and currently operates in 12 states with 52 dispensaries, 14 cultivation sites and 14 processing sites. Curaleaf has the executive expertise and research and development capabilities to provide leading service, selection, and accessibility across the medical and adult-use markets, as well as in the CBD category through its Curaleaf Hemp brand.
